Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06765018Not ApplicableCompleted

Tongue Brush (Orabrush) for Reducing Aspiration Pneumonia in Stroke Patients

Role: lead

NCT07443241Completed

Status Epilepticus in Men and Women: Clinical Presentation, Management, and Outcomes

Role: lead

NCT06013761Not ApplicableCompleted

IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy

Role: lead

NCT06836687Recruiting

Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure

Role: lead

NCT06540378Completed

Stiripentol for the Treatment of Refractory Status Epilepticus

Role: lead

All 5 trials loaded